Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3397391
Max Phase: Preclinical
Molecular Formula: C28H26F3N3O5S
Molecular Weight: 573.59
Molecule Type: Small molecule
Associated Items:
ID: ALA3397391
Max Phase: Preclinical
Molecular Formula: C28H26F3N3O5S
Molecular Weight: 573.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cc2c(cc1S(=O)(=O)N1CCN(c3ccc(C(F)(F)F)cc3)CC1)N(CC(=O)c1ccccc1)C(=O)CO2
Standard InChI: InChI=1S/C28H26F3N3O5S/c1-19-15-25-23(34(27(36)18-39-25)17-24(35)20-5-3-2-4-6-20)16-26(19)40(37,38)33-13-11-32(12-14-33)22-9-7-21(8-10-22)28(29,30)31/h2-10,15-16H,11-14,17-18H2,1H3
Standard InChI Key: JWSQEZPWCZEAOL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 573.59 | Molecular Weight (Monoisotopic): 573.1545 | AlogP: 4.13 | #Rotatable Bonds: 6 |
Polar Surface Area: 87.23 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.90 | CX LogP: 4.03 | CX LogD: 4.03 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.41 | Np Likeness Score: -1.73 |
1. Konda S, Raparthi S, Bhaskar K, Munaganti RK, Guguloth V, Nagarapu L, Akkewar DM.. (2015) Synthesis and antimicrobial activity of novel benzoxazine sulfonamide derivatives., 25 (7): [PMID:25754493] [10.1016/j.bmcl.2015.01.026] |
Source(1):